A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer



Lungenkrebszentrum Ostercappeln, Sektion Thoraxchirurgie, Franziskus Hospital Harderberg

Niels Stensen Kliniken
Alte Rothenfelder Strasse 23
49124 Georgsmarienhütte

Dr. Petra Hoffknecht
Franziskus Hospital Harderberg

Vorherige Studie
Nächste Studie
to top icon